Cancer targeting Gene-Viro-Therapy specific for liver cancer by α-fetoprotein-controlled oncolytic adenovirus expression of SOCS3 and IL-24

Acta Biochimica et Biophysica Sinica

Volumn 43, Issue 10, 2011, Pages 813-821

  Cao, Xin ^a   Wei, Ruicheng ^a,b,c   Liu, Xinran ^a   Zeng, Yan ^c   Huang, Hongling ^a   Ding, Miao ^a   Zhang, Kangjian ^a   Liu, Xin Yuan ^a,b  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b ZHEJIANG SCI TECH UNIVERSITY   (China)

^c INSTITUTE PASTEUR OF SHANGHAI   (China)

Author keywords

apoptosis; cancer biotherapy; interleukin 24; oncolytic adenovirus; suppressor of cytokine signaling 3

Indexed keywords

ALPHA FETOPROTEIN; INTERLEUKIN 24; INTERLEUKIN DERIVATIVE; INTERLEUKIN-24; SOCS3 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING;

ADENOVIRUS; ANIMAL; ARTICLE; DRUG SCREENING; GENE EXPRESSION REGULATION; GENE THERAPY; GENETICS; HUMAN; LIVER TUMOR; METABOLISM; METHODOLOGY; MOUSE; NUDE MOUSE; ONCOLYTIC VIROTHERAPY; PATHOLOGY; TUMOR CELL CULTURE;

ADENOVIRIDAE; ALPHA-FETOPROTEINS; ANIMALS; GENE EXPRESSION REGULATION; GENE THERAPY; HUMANS; INTERLEUKINS; LIVER NEOPLASMS; MICE; MICE, NUDE; ONCOLYTIC VIROTHERAPY; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ADENOVIRIDAE; MUS MUSCULUS;

EID: 80053557123     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmr071     Document Type: Article

References (23)

1. Bainbridge JW, Smith AJ, Barker SS, Robbie S, Henderson R, Balaggan K and Viswanathan A, et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med 2008, 358: 2231-2239. (Pubitemid 351724452)
2. Maguire AM, Simonelli F, Pierce EA, Pugh EN, Jr, Mingozzi F, Bennicelli J and Banfi S, et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med 2008, 358: 2240-2248. (Pubitemid 351724453)
3. Cartier N, Hacein-Bey-Abina S, Bartholomae CC, Veres G, Schmidt M, Kutschera I and Vidaud M, et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 2009, 326: 818-823.
4. Aiuti A, Cattaneo F, Galimberti S, Benninghoff U, Cassani B, Callegaro L and Scaramuzza S, et al. Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med 2009, 360: 447-458.
5. Huebner RJ, Rowe WP, Schatten WE, Smith RR and Thomas LB. Studies on the use of viruses in the treatment of carcinoma of the cervix. Cancer 1956, 9: 1211-1218.
6. Martuza RL, Malick A, Markert JM, Ruffner KL and Coen DM. Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science 1991, 252: 854-856. (Pubitemid 121000529)
7. Barker DD and Berk AJ. Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection. Virology 1987, 156: 107-121. (Pubitemid 17013653)
8. Garber K. China approves world's first oncolytic virus therapy for cancer treatment. J Natl Cancer Inst 2006, 98: 298-300.
9. Zhang ZL, Zou WG, Luo CX, Li BH, Wang JH, Sun LY and Qian QJ, et al. An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy. Cell Res 2003, 13: 481-489. (Pubitemid 43231842)
10. Liu XY. A new anticancer strategy-Gene-Viro-Therapy of cancer. Chin J Cancer Biother 2001, 8: 1.
11. Hermiston T. Fighting fire with fire: Attacking the complexity of human tumors with armed therapeutic viruses. Curr Opin Mol Ther 2002, 4: 334-342. (Pubitemid 36305024)
12. Cao X, Yang M, Wei RC, Zeng Y, Gu JF, Huang WD and Yang DQ, et al. Cancer targeting Gene-Viro-Therapy of liver carcinoma by dualregulated oncolytic adenovirus armed with TRAIL gene. Gene Ther 2011, doi:10.1038/gt.2011.16.
13. Jiang H, Lin JJ, Su ZZ, Goldstein NI and Fisher PB. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 1995, 11: 2477-2486. (Pubitemid 26023815)
14. Gupta P, Su ZZ, Lebedeva IV, Sarkar D, Sauane M, Emdad L and Bachelor MA, et al. mda-7/IL-24: Multifunctional cancer-specific apoptosis-inducing cytokine. Pharmacol Ther 2006, 111: 596-628. (Pubitemid 44118431)
15. Dent P, Yacoub A, Hamed HA, Park MA, Dash R, Bhutia SK and Sarkar D, et al. The development of MDA-7/IL-24 as a cancer therapeutic. Pharmacol Ther 2010, 128: 375-384.
16. Niwa Y, Kanda H, Shikauchi Y, Saiura A, Matsubara K, Kitagawa T and Yamamoto J, et al. Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma. Oncogene 2005, 24: 6406-6417. (Pubitemid 41486474)
17. Calvisi DF, Ladu S, Gorden A, Farina M, Conner EA, Lee JS and Factor VM, et al. Ubiquitous activation of Ras and Jak/Stat pathways in human HCC. Gastroenterology 2006, 130: 1117-1128.
18. Cui Q, Jiang W, Wang Y, Lv C, Luo J, Zhang W and Lin F, et al. Transfer of suppressor of cytokine signaling 3 by an oncolytic adenovirus induces potential antitumor activities in hepatocellular carcinoma. Hepatology 2008, 47: 105-112. (Pubitemid 351171047)
19. Chou TC and Talalay P. Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984, 22: 27-55.
20. Wei RC, Cao X, Gui JH, Zhou XM, Zhong D, Yan QL and Huang WD, et al. Augmenting the antitumor effect of TRAIL by SOCS3 with doubleregulated replicating oncolytic adenovirus in hepatocellular carcinoma. Hum Gene Ther 2011, doi:10.1089/hum.2010.219.
21. Sauane M, Gopalkrishnan RV, Lebedeva I, Mei MX, Sarkar D, Su ZZ and Kang DC, et al. Mda-7/IL-24 induces apoptosis of diverse cancer cell lines through JAK/STAT-independent pathways. J Cell Physiol 2003, 196: 334-345. (Pubitemid 36775881)
22. Johnson M, Huyn S, Burton J, Sato M and Wu L. Differential biodistribution of adenoviral vector in vivo as monitored by bioluminescence imaging and quantitative polymerase chain reaction. Hum Gene Ther 2006, 17: 1262-1269. (Pubitemid 44975142)
23. Waddington SN, McVey JH, Bhella D, Parker AL, Barker K, Atoda H and Pink R, et al. Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 2008, 132: 397-409. (Pubitemid 351200513)